BlackRock Fund Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $78M | Buy |
2,704,309
+150,022
| +6% | +$4.33M | 0.01% | 1388 |
|
|
2016
Q3 | $81.3M | Buy |
2,554,287
+214,275
| +9% | +$6.82M | 0.02% | 1235 |
|
|
2016
Q2 | $76M | Sell |
2,340,012
-1,209,066
| -34% | -$39.2M | 0.02% | 1200 |
|
|
2016
Q1 | $99.2M | Buy |
3,549,078
+349,519
| +11% | +$9.77M | 0.02% | 962 |
|
|
2015
Q4 | $114M | Sell |
3,199,559
-191,052
| -6% | -$6.81M | 0.03% | 858 |
|
|
2015
Q3 | $112M | Buy |
3,390,611
+183,527
| +6% | +$6.07M | 0.03% | 818 |
|
|
2015
Q2 | $134M | Sell |
3,207,084
-69,296
| -2% | -$2.9M | 0.03% | 763 |
|
|
2015
Q1 | $107M | Buy |
3,276,380
+84,595
| +3% | +$2.76M | 0.03% | 940 |
|
|
2014
Q4 | $101M | Buy |
3,191,785
+264,873
| +9% | +$8.41M | 0.03% | 940 |
|
|
2014
Q3 | $72.5M | Sell |
2,926,912
-9,031
| -0.3% | -$224K | 0.02% | 1093 |
|
|
2014
Q2 | $66.3M | Sell |
2,935,943
-131,727
| -4% | -$2.98M | 0.02% | 1210 |
|
|
2014
Q1 | $74.6M | Buy |
3,067,670
+276,101
| +10% | +$6.72M | 0.02% | 1086 |
|
|
2013
Q4 | $69.8M | Sell |
2,791,569
-1,133
| -0% | -$28.3K | 0.02% | 1142 |
|
|
2013
Q3 | $76.7M | Buy |
2,792,702
+371,913
| +15% | +$10.2M | 0.03% | 970 |
|
|
2013
Q2 | $43.9M | Buy |
+2,420,789
| New | +$43.9M | 0.02% | 1313 |
|